Natural compounds targeting nuclear receptors for effective cancer therapy

Mangala Hegde1, Sosmitha Girisa1, Nikunj Naliyadhara1

  • 1Cancer Biology Laboratory, Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati, 781039, Assam, India.

Cancer Metastasis Reviews
|December 9, 2022
PubMed

Insights

Natural compounds targeting nuclear receptors (NRs) show promise as safe cancer treatments. This review explores phytochemicals, dietary components, and other natural compounds for novel oncology drug discovery.

Area of Science:

  • Molecular Biology
  • Oncology
  • Pharmacology

Background:

  • Human nuclear receptors (NRs) are transcription factors regulating critical biological processes.
  • Dysregulated NRs and their signaling pathways are implicated in cancer development.
  • Targeting NRs is a key strategy in cancer drug development.

Purpose of the Study:

  • To review the therapeutic potential of natural compounds targeting NRs for cancer treatment.
  • To highlight molecular mechanisms and signaling pathways involved in the anti-cancer effects of these natural compounds.
  • To assess current preclinical and clinical studies on natural compounds for cancer prophylaxis.

Main Methods:

  • Literature review of preclinical and clinical studies.
  • Analysis of molecular mechanisms and signaling pathways.
  • Critical assessment of natural compound classes including phytochemicals, dietary components, venom constituents, royal jelly derivatives, and microbial derivatives.

Main Results:

  • Natural compounds, including phytochemicals and dietary components, demonstrate significant potential as anti-cancer agents by targeting NRs.
  • Various molecular mechanisms and signaling pathways are exploited by these natural compounds to exert anti-cancer effects.
  • Current research indicates advantages and limitations in using natural compounds for cancer intervention and prophylaxis.

Conclusions:

  • Naturally occurring compounds offer a promising avenue for developing novel, safe, and effective cancer medications.
  • Further research into molecular mechanisms and clinical studies is needed to fully realize the potential of NR-targeting natural compounds.
  • This review may guide new paradigms in discovering targeted cancer drugs.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.5K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Drug-Receptor Bonds01:25

Drug-Receptor Bonds

Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
3.1K
Signal Transduction: Overview01:26

Signal Transduction: Overview

Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
8.8K